Iatrogenic immunosuppression with biologics in MS: expecting the unexpected?

Stüve, Olaf

Iatrogenic immunosuppression with biologics in MS: expecting the unexpected? [electronic resource] - Neurology Oct 2009 - 1346-7 p. digital

Publication Type: Comment; Editorial

1526-632X

10.1212/WNL.0b013e3181beed38 doi


Animals
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Clinical Trials as Topic
Humans
Iatrogenic Disease
Immune Tolerance
Integrin alpha4--metabolism
Leukoencephalopathy, Progressive Multifocal--chemically induced
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Natalizumab
Risk
Toxoplasma
Toxoplasmosis, Ocular--etiology